Radiko Holdings Corp.
Radiko Holdings Corp.
Your view on GEATF
Overview
What the company does, where it operates, and who runs it.
About Radiko Holdings Corp.
- Industry
- Medical - Pharmaceuticals
- Sector
- Healthcare
- CEO
- Scott Michael Reeves
- Headquarters
- PO Box 13039, Des Moines, WA, US
- Industry
- Medical - Pharmaceuticals
- Sector
- Healthcare
- CEO
- Scott Michael Reeves
- Headquarters
- PO Box 13039, Des Moines, WA, US
Radiko Holdings Corp., together with its subsidiaries, focuses on cannabis industries in the United States and internationally.
The company also manufactures and distributes a range of cannabis infused edibles and tinctures under the La Vida Verde brand; a range of wholesale flower, packaged flower, pre-rolls, and concentrates under the Skunk Feather brand; a range of cannabis, infused, chocolates, and edible cannabis consumables gummies, and capsules under the name the Blank Brand; and supplements under the Baseline brand.
The company was formerly known as International Cannabrands Inc. and changed its name to Radiko Holdings Corp. in July 2020. The company is headquartered in Des Moines, Washington.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Radiko Holdings Corp., and the rating behind it. GEATF last traded at $0.0000; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Radiko Holdings Corp.. Starting points for Radiko Holdings Corp.: EPS -$0.04, beta 7.43 — an Medical - Pharmaceuticals name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Radiko Holdings Corp.. Radiko Holdings Corp. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Radiko Holdings Corp.. Trailing twelve-month EPS for Radiko Holdings Corp. stands at -$0.04. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Radiko Holdings Corp.. Radiko Holdings Corp. has reported as a listed company since 2017. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Radiko Holdings Corp. valued side by side against its closest peers. Radiko Holdings Corp. is measured against Medical - Pharmaceuticals peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Radiko Holdings Corp., and how their positions are changing. At a $4,453 market value, institutional positions materially move Radiko Holdings Corp.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Radiko Holdings Corp. executives and directors. Shares of Radiko Holdings Corp. have traded between $0.0000 and $0.0000 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Radiko Holdings Corp.. Radiko Holdings Corp. is a $4,453 Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Radiko Holdings Corp.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Radiko Holdings Corp.. Coverage tracks Radiko Holdings Corp. within Medical - Pharmaceuticals (Healthcare). Press releases and market coverage, newest first.